Nutex Health (NASDAQ:NUTX - Get Free Report) will be announcing its earnings results after the market closes on Thursday, November 7th.
Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.22. The firm had revenue of $76.08 million for the quarter. Nutex Health had a negative return on equity of 43.79% and a negative net margin of 13.73%.
Nutex Health Price Performance
Shares of NASDAQ NUTX traded up $0.31 during midday trading on Friday, reaching $22.60. 46,728 shares of the company traded hands, compared to its average volume of 40,425. Nutex Health has a 12 month low of $4.16 and a 12 month high of $45.00. The company has a debt-to-equity ratio of 3.04, a quick ratio of 1.55 and a current ratio of 1.59. The stock's 50-day simple moving average is $22.07 and its 200-day simple moving average is $12.65. The firm has a market cap of $114.58 million, a PE ratio of -2.47 and a beta of 0.10.
Insider Activity at Nutex Health
In related news, CFO Jon Christian Bates acquired 1,350 shares of the firm's stock in a transaction on Thursday, August 22nd. The shares were purchased at an average price of $21.46 per share, with a total value of $28,971.00. Following the acquisition, the chief financial officer now directly owns 2,277 shares in the company, valued at $48,864.42. The trade was a 100.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 38.52% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the stock. Benchmark boosted their price target on shares of Nutex Health from $30.00 to $45.00 and gave the company a "buy" rating in a research report on Wednesday, August 21st. Maxim Group assumed coverage on Nutex Health in a research report on Wednesday, September 18th. They set a "buy" rating and a $45.00 price target on the stock.
Get Our Latest Stock Report on NUTX
About Nutex Health
(
Get Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Read More
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
